Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview
- PMID: 33171587
- PMCID: PMC7664638
- DOI: 10.3390/ijms21218368
Dietary Carbohydrates and Lipids in the Pathogenesis of Leaky Gut Syndrome: An Overview
Abstract
This review summarizes the recent knowledge on the effects of dietary carbohydrates and lipids on the pathophysiology of leaky gut syndrome (LGS). Alterations in intestinal barrier permeability may lead to serious gastrointestinal (GI) disorders. LGS is caused by intestinal hyperpermeability due to changes in the expression levels and functioning of tight junctions. The influence of dietary habits on intestinal physiology is clearly visible in incidence rates of intestinal diseases in industrial and developing countries. Diseases which are linked to intestinal hyperpermeability tend to localize to Westernized countries, where a diet rich in fats and refined carbohydrates predominates. Several studies suggest that fructose is one of the key carbohydrates involved in the regulation of the intestinal permeability and its overuse may cause harmful effects, such as tight junction protein dysfunction. On the other hand, short chain fatty acids (mainly butyrate) at appropriate concentrations may lead to the reduction of intestinal permeability, which is beneficial in LGS. However, long chain fatty acids, including n-3 and n-6 polyunsaturated fatty acids have unclear properties. Some of those behave as components untightening and tightening the intestinal membrane.
Keywords: carbohydrates; leaky gut syndrome; lipids.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Van der Sluis M., De Koning B.A.E., De Bruijn A.C.J.M., Velcich A., Meijerink J.P.P., Van Goudoever J.B., Büller H.A., Dekker J., Van Seuningen I., Renes I.B., et al. Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is Critical for Colonic Protection. Gastroenterology. 2006;131:117–129. doi: 10.1053/j.gastro.2006.04.020. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- #503/1-156-04/503-01 to MS/Medical University of Lodz
- POIR.04.04.00-00-420C/17-00/TEAM program of the Foundation for Polish Science
- 0229/DIA/2019/48/Diamentowy Grant program of the Ministry of Science and Higher Education
- PPN/BEK/2019/1/00015/DEC/1/Bekker program fellowship funded by the Polish National Agency for Academic Exchange
LinkOut - more resources
Full Text Sources
Medical
